Overall Technical outlook

Price Summary

On 2025-10-17, Ipca Laboratories Limited's stock began at 1297.0, peaked at 1297.0, declined to 1280.0, and ended the day -0.82% down at 1286.3, with 50847 shares traded.
The stock's highest price over the 52-week span is 1744.05, while the lowest price is 1286.3.
Based on recommendations from 16 analysts, the future price of IPCALAB is expected to range from 1135.0 to 1767.0, with an average price expectation around 1513.0625.

Technicals


Aroon: The AROON is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
IPCALAB aroon 1cb42a
Aroon chart for Ipca Laboratories Limited


Bol. Bands: The BOLL BANDS is in a neutral stance for IPCALAB, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
IPCALAB bbands 1cb42a
Bolinger Bands chart for Ipca Laboratories Limited


Parabolic SAR: The PSAR maintains a bearish outlook for IPCALAB, establishing a key resistance level that could limit further gains. This ongoing bearish trend suggests that the market may struggle to overcome this resistance, keeping upward movement subdued.
IPCALAB psar 1cb42a
Parabolic Stop and Reverse chart for Ipca Laboratories Limited


Stochastic: With the Stochastic K-line below the D-line and under 20, the market shows signs of a mildly bearish trend. This configuration suggests possible weakness for IPCALAB, but the bearish sentiment is not overly strong. Traders should be aware of this potential shift and look for further confirmation.
IPCALAB stoch 1cb42a
Stochastic chart for Ipca Laboratories Limited


Tripple Moving Agerage: A bullish trend for Ipca Laboratories Limited is reflected in the alignment of the 20-50-100 period moving averages, though the slopes of the faster averages raise concerns about a potential reversal. The weakening momentum in the shorter-term averages suggests that the current trend may not last, signaling the possibility of a shift in direction.
IPCALAB trippleSMA 1cb42a
Tripple SMA chart for Ipca Laboratories Limited


In order to draw meaningful inferences from a company's technical data, it is essential to first consider its fundamentals. This includes reviewing financial metrics like revenue, profit margins, and debt-to-equity ratios. Additionally, understanding the broader industry landscape, including market trends and competitive pressures, is crucial. By integrating these insights with the company's technical performance, such as stock price fluctuations and trading volume, one can make more informed investment decisions.